Phenylacetate is an inhibitor of prostatic growth and development in organ culture

Journal of Urology

Volumn 155, Issue 5, 1996, Pages 1762-1770

  Lipschutz, Joshua H ^b   Samid, Dvorit ^b   Cunha, Gerald R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

organ culture; phenylacetates; prostate

Indexed keywords

ARYLBUTYRIC ACID DERIVATIVE; CYTOKERATIN; DNA; GLUTAMINE; GLYCINE; HYDROCORTISONE; INSULIN; MONOCLONAL ANTIBODY; PHENYLACETIC ACID; TESTOSTERONE; TRANSFERRIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; MALE; NEWBORN; NONHUMAN; ORGAN CULTURE; ORGAN GROWTH; ORGANOGENESIS; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATE VENTRAL LOBE; RAT;

EID: 0029984355     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66194-9     Document Type: Article

References (54)

1. Sandler, M., Ruthven, C. R. J., Goodwin, B. L., Lee, A. and Stern, G. M.: Phenylacetic acid in human body fluids: high correlation between plasma and cerebrospinal fluid concentration values. J. Neurol. Neurosurg. Psychol., 45: 366, 1982.
2. James, M. O., Smith, R. L., Williams, R. T. and Reidenberg, M.: The conjugation of phenylacetic acid in man, sub-human primates, and some non-primate species. Proc. R. Soc. Lond. B. Biol. Sci., 182: 25, 1972.
3. Brusilow, S. W., Danney, M., Waber, L. J., Batshaw, M., Burton, B., Levitsky, L., Roth, K., McKeethren, C. and Ward, J.: Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis. N. Engl. J. Med., 310: 1630, 1984.
4. Brusilow, S. W.: Phenylacetylglutamine may replace urea as a vehicle for waste nitrogen excretion. Pediatr. Res., 29: 147, 1991.
5. Mendenhall, C. L., Rouster, S., Marshall, L. and Weesner, R.: A new therapy for portal systemic encephalopathy. Am. J. Gastroenterol., 81: 540, 1986.
6. Simell, O., Sipila, I., Rajantie, J., Valle, D. L. and Brusilow, S. W.: Waste nitrogen excretion via amino acid acylation: benzoate and phenylacetate in lysinuric protein intolerance. Pediatr. Res., 20: 1117, 1986.
7. Eisner, T., Conner, W. E., Hicks, K., Dodge, K. R., Rosenberg, H. I., Jones, T. H., Cohen, M. and Meinwald, J.: Stink of stinkpot turtle identified: phenylalkanoic acids. Science, 196: 1347, 1977.
8. Wightman, F. and Lighty, D. C.: Identification of phenylacetic acid as a natural auxin in the shoots of higher plants. Physiol. Plant, 55: 17, 1982.
9. Nuti, M. P., De Bertoldi, M. and Lepidi, A. A.: Influence of phenylacetic acid on poly-β-hydroxybutyrate polymerization and cell elongation in Asobacter chroococcum beij. Can. J. Microbiol., 18: 1257, 1972.
10. Kishore, G., Sugumaran, M. and Vaidyanathan, C. S.: Metabolism of DL-phenylalanine by Aspergillus niger. J. Bacteriol., 128: 182, 1976.
11. Cinatl, J., Cinatl, J., Mainke, M., Weissflog, A., Rabenau, H., Kornhuber, B. and Doerr, H.: In vitro differentiation of human neuroblastoma cells induced by sodium phenylacetate. Cancer Lett., 70: 15, 1993.
12. Samid, D., Yen, A. and Prasanna, P.: Induction of erythroid differentiation and fetal hemoglobin production in human leukemic cells treated with phenylacetate. Blood, 80: 1576, 1992.
13. Samid, D., Shack, S. and Sherman, L. T.: Phenylacetate: a novel nontoxic inducer of tumor cell differentiation. Cancer Res., 52: 1988, 1992.
14. Call, T. G., Stenson, M. J. and Witzig, T. E.: Effects of phenylacetate on cells from patients with B-chronic lymphocytic leukemia. Leuk. Lymphoma, 14: 145, 1994.
15. Ram, Z., Samid, D., Walbridge, S., Oshiro, E. M., Viola, J. J., Tao-Cheng, J., Shack, S., Thibault, A., Myers, C. E. and Oldfield, E. H.: Growth inhibition, tumor maturation, and extended survival in experimental brain tumors in rats treated with phenylacetate. Cancer Res., 54: 2923, 1994.
16. Liu, L., Shack, S., Stetler-Stevenson, W. G., Hudgins, W. R. and Samid, D.: Differentiation of cultured human melanoma cells induced by the aromatic fatty acids phenylacetate and phenylbutyrate. J. Invest. Dermatol., 103: 335, 1994.
17. Cinatl, J., Cinatl, J., Herneiz, P., Rabenau, H., Novak, M., Benda, R., Gumbel, H. O., Kornhuber, B. and Doerr, H.: Induction of myogenic differentiation in a human rhabdomyosarcoma cell line by phenylacetate. Cancer Lett., 78: 41, 1994.
18. Samid, D., Shack, S. and Myers, C. E.: Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate. J. Clin. Invest. 91: 2288, 1993.
19. Thibault, A., Cooper, M. R., Figg, W. D., Venzon, D. J., Sartor, O., Tompkins, A. E., Weinberger, M. S., Headlee, D. J., McCall, N. A., Samid, D. and Myers, C. E.: A phase 1 and pharmacokinetic study of intravenous phenylacetate in patients with cancer. Cancer Res., 54: 1690, 1994.
20. Mostofi, F. K. and Davis, C. J. J.: Male reproductive system and prostate. Andersons Pathology. Edited by J. M. Kissane. St. Louis: C. V. Mosby Co., chapt. 19, pp. 871-919, 1990.
21. Walsh, P. C.: Human benign prostatic hyperplasia: etiological considerations. Prog. Clin. Biol. Res., 145: 1, 1984.
22. Rotkin, I. D.: Origins, distribution and risk of benign prostatic hypertrophy. In: Benign Prostatic Hypertrophy. Edited by F. Hinman. New York: Springer-Verlag, pp. 10-21, 1983.
23. McNeal, J. E.: The prostate gland: morphology and pathobiology. Monogr. Urol., 4: 3, 1983.
24. McNeal, J. E.: Origin and evolution of benign prostatic enlargement. Invest. Urol., 15: 340, 1978.
25. Shima, H., Tsuji, M., Young, P. F. and Cunha, G. R.: Postnatal growth of mouse seminal vesicle is dependent on 5α-dihydrotestosterone. Endocrinology, 127: 3222, 1990.
26. Higgins, S. J., Young, P., Brody, J. R. and Cunha, G. R.: Induction of functional cytodifferentiation in the epithelium of tissue recombinants. I. Homotypic seminal vesicle recombinants. Development, 106: 219, 1989.
27. Lane, E. B.: Monoclonal antibodies provide specific intramolecular markers for the study of epithelial tonofilament organization. J. Cell Biol., 92: 665, 1982.
28. Prins, G., Birch, L. and Greene, G.: Androgen receptor localization in different cell types of the adult rat prostate. Endocrinology, 129: 3187, 1991.
29. Cunha, G. R., Alarid, E. T., Turner, T., Donjacour, A. A., Boutin, E. L. and Foster, B. A.: Normal and abnormal development of the male urogenital tract: role of androgens, mesenchymal-epithelial interactions and growth factors. J. Androl., 13: 465, 1992.
30. Sugimura, Y., Cunha, G. R. and Donjacour, A. A.: Morphogenesis of ductal networks in the mouse prostate. Biol. Reprod., 34: 961, 1986.
31. Verhagen, A. P. M., Aalders, T. W., Ramaekers, F. C. S., Debruyne, F. M. J. and Schalken, J. A.: Differential expression of keratins in the basal and luminal compartments of rat prostatic epithelium during degeneration and regeneration. Prostate, 13: 25, 1988.
32. Peehl, D. M., Leung, G. K. and Wong, S. T.: Keratin expression: a measure of phenotypic modulation of human prostatic epithelial cells by growth inhibitory factors. Cell Tissue Res., 277: 11, 1994.
33. Prins, G. S. and Birch, L.: The developmental pattern of androgen receptor expression in rat prostate lobes is altered after neonatal exposure to estrogen. Endocrinology, 136: 1303, 1995.
34. Sidell, N., Wada, R., Han, G., Chang, B., Shack, S., Moore, T. and Samid, D.: Phenylacetate synergizes with retinoic acid in inducing the differentiation of human neuroblastoma cells. Int. J. Cancer, 60: 507, 1995.
35. Samid, D., Ram, Z., Hudgins, W. R., Shack, S., Liu, L., Walbridge, S., Oldfield, E. and Meyers, C. E.: Selective activity of phenylacetate against gliomas: resemblance to fetal brain damage in phenylketonuria. Cancer Res., 54: 891, 1994.
36. Lee, C., Kozlowski, J. M. and Grayhack, J. T.: Etiology of benign prostatic hyperplasia. Urol. Clin. North Am., 22: 237, 1995.
37. Oesterling, J. E.: The origin and development of benign prostatic hyperplasia. J. Androl., 12: 348, 1991.
38. Reischauer, F.: Die entstehung der sogenannten prostatahypertropie. Virchows Arch. B., 256: 357, 1925.
39. Cunha, G. R., Fujii, H., Neubauer, B. L., Shannon, J. M., Sawyer, L. M. and Reese, B. A.: Epithelial-mesenchymal interactions in prostatic development. I. Morphological observations of prostatic induction by urogenital sinus mesenchyme in epithelium of the adult rodent urinary bladder. J. Cell Biol., 96: 1662, 1983.
40. Cunha, G. R., Chung, L. W. K., Shannon, J. M., Taguchi, O. and Fujii, H.: Hormone-induced morphogenesis and growth: role of mesenchymal-epithelial interactions. Recent Prog. Horm. Res., 39: 559, 1983.
41. Cunha, G. R., Bigsby, R. M., Cooke, P. S. and Sugimura, Y.: Stromal-epithelial interactions in adult organs. Cell Diff., 17: 137, 1985.
42. Chung, L. W. K. and Cunha, G. R.: Stromal-epithelial interactions. II. Regulation of prostatic growth by embryonic urogenital sinus mesenchyme. Prostate, 4: 503, 1983.
43. Miller, G. J., Runner, M. N. and Chung, L. W.: Tissue interactions and prostatic growth. II. Morphological and biochemical characterization of adult mouse prostatic hyperplasia induced by fetal urogenital sinus implants. Prostate, 6: 241, 1985.
44. Yan, G., Fukabori, Y., Nikolaropoulos, S., Wang, F. and McKeehan, W. L.: Heparin-binding keratinocyte growth factor is a candidate stromal to epithelial cell andromedin. Mol. Endocrinol., 6: 2123, 1992.
45. Vermuelen, A., Rubens, R. and Verdonch, L.: Testosterone secretion and metabolism in male senescence. J. Clin. Endocrinol. Metab., 34: 730, 1972.
46. Marshall, C. J.: Protein prenylation: a mediator of protein-protein interactions. Science, 259: 1865, 1993.
47. Krontiris, T. G.: Oncogenes. N. Engl. J. Med., 333: 303, 1995.
48. Fibach, E., Prasanna, P., Rodgers, G. P. and Samid, D.: Enhanced fetal hemoglobin production by phenylacetate and 4-phenylbutyrate in erythroid precursor derived from normal donors and patients with sickle cell anemia and beta-thalassemia. Blood, 82: 2203, 1993.
49. George, J., Dover, G. J., Brusilow, S. and Samid, D.: Increased fetal hemoglobin in patients receiving sodium 4-phenylbutyrate. N. Engl. J. Med., 327: 569, 1992.
50. Serra, R., Pelton, R. W. and Moses, H. L.: TGFβ1 inhibits branching morphogenesis and N-myc expression in lung bud organ cultures. Development, 120: 2153, 1994.
51. Marcu, K. B., Bossone, S. A. and Patel, A. J.: Myc function and regulation. Annu. Rev. Biochem., 61: 809, 1992.
52. Mugrauer, G., Alt, F. and Ekblom, P.: N-myc proto-oncogene expression during organogenisis in the developing mouse as revealed by in situ hybridization. J. Cell Biol., 107: 1325, 1988.
53. Sawai, S. A. S., Wakamatsu, Y., Palmes, C., Hanaoka, K. and Kondoh, H.: Defects of embryonic organogenesis resulting from targeted disruption of the N-myc gene in the mouse. Development, 117: 1445, 1993.
54. Stanton, B. R., Perkins, A. S., Tessarollo, L., Sassoon, D. A. and Parada, L. F.: Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes Dev., 6: 2235, 1992.